X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - ZACKS.COM - All Stories - 01/Jul 12:44

Apellis (APLS) Falls on Second Negative CHMP Opinion for GA Drug

Apellis (APLS) declines as CHMP issues a second negative opinion for the approval of intravitreal pegcetacoplan to treat GA in the EU. The company plans to seek re-examination of the same.

Articles similaires

Sorry! Image not available at this time

Apellis' (APLS) Syfovre Boost Sales, Regulatory Setbacks a Woe

zacks.com - 05/Jul 12:41

Apellis' (APLS) revenues rise on the back of the robust uptake of Syfovre for the GA indication. However, the recent regulatory setback in the EU for...

Sorry! Image not available at this time

Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab

zacks.com - 03/Jul 12:34

Eli Lilly's (LLY) Alzheimer's disease drug, Kisunla (donanemab), wins FDA approval. Kisunla will be the second drug on the market to treat the...

Sorry! Image not available at this time

FDA Approves New Drug to Treat Alzheimer's, Kisunla

drugs.com - 02/Jul 19:07

TUESDAY, July 2, 2024 -- A new drug to treat Alzheimer's disease was approved by the U.S. Food and Drug Administration on Tuesday. In clinical trials,...

Sorry! Image not available at this time

AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use

zacks.com - 02/Jul 15:00

The CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary advanced or recurrent endometrial cancer based on data...

Sorry! Image not available at this time

AstraZeneca (AZN) Imfinzi Combo Gets CHMP Nod for Expanded Use

zacks.com - 02/Jul 15:00

The CHMP recommends approval of AstraZeneca's (AZN) Imfinzi plus Lynparza for treating primary advanced or recurrent endometrial cancer based on data...

Sorry! Image not available at this time

Immutep announces positive results from TACTI─003 phase IIb trial of efti in combo with Keytruda to treat HNSCC patients with negative PD─L1 expression

pharmabiz.com - 00:00

Immutep Limited (Immutep), a clinical─stage biotechnology company developing novel LAG─3 immunotherapies for cancer and autoimmune disease,...

Sorry! Image not available at this time

200-bed rehab center for drug addicts set up in Daikundi

pajhwok.com - 11/Jul 12:18

A 200-beded rehabilitation center has been set up to treat drug addicts in Neili city, the capital of central Daikundi province.

Sorry! Image not available at this time

'Dravid declines higher bonus, opts for equal pay with staff'

times of india - 10/Jul 02:31

India's outgoing head coach, Rahul Dravid, has declined an additional Rs 2.5 crore bonus offered by the Board of Control for Cricket in India for...

Sorry! Image not available at this time

'Dravid declines higher bonus, opts for equal pay with staff'

times of india - 10/Jul 02:31

India's outgoing head coach, Rahul Dravid, has declined an additional Rs 2.5 crore bonus offered by the Board of Control for Cricket in India for...

Sorry! Image not available at this time

Genentech to Reintroduce Susvimo for People With Wet Age-Related Macular Degeneration (AMD)

drugs.com - 08/Jul 00:07

South San Francisco, CA -- July 8, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today the reintroduction of...

Les derniers communiqués